Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2009
10/14/2009CN101554438A Traditional Chinese medicine for curing hemorrhoids
10/14/2009CN101554427A Traditional Chinese medicine compound gel for treating osteoporosis and preparation method thereof
10/14/2009CN101554405A Selfheal, mulberry leaf and wild chrysanthemum dripping pills and preparation method thereof
10/14/2009CN101554391A American ginseng acanthopanax traditional Chinese medicine preparation for treating neurasthenia
10/14/2009CN101554386A Medicine composition for curing hepatic disease and preparation method thereof
10/14/2009CN101554381A Candesartan cilexetil hydrochlorothiazide double-layer tablets and preparation mehtod thereof
10/14/2009CN101554376A High-bioavailability rapamycin composition and preparation method thereof
10/14/2009CN101554373A Caffeic acid composition and preparation method thereof
10/14/2009CN101554372A Calcitriol dripping pill and preparation method thereof
10/14/2009CN101554371A Preparation and application of Silybin/Silymarin polymer micelle
10/14/2009CN101554369A External spraying agent and eye drop of compound oil nano-emulsion as well as preparation method thereof
10/14/2009CN101554368A Tetrodotoxin composition formulation stable at room temperature and used for injection
10/14/2009CN101554367A Method for preparing sulfhydryl carboxymethyl chitosan microgel applicable to mucosa delivery
10/14/2009CN101554366A Method for preparing carboxymethyl chitose gel applicable to site-specific delivery drugs in gastrointestinal tract
10/14/2009CN101554364A Bulleyaconitine A micro-balloons and bulleyaconitine A long-acting injection and preparation method and application of same
10/14/2009CN100549064C Perfluoropolyether containing acryloyl groups
10/14/2009CN100549044C Biodegradable crosslinked polyethylenimine and its uses
10/14/2009CN100548386C Releasable polymeric conjugates based on biodegradable linkers
10/14/2009CN100548383C Method and compositions for prevention or treatment of cancer
10/14/2009CN100548382C Drug carrier and method for preparing same
10/14/2009CN100548381C Bitterness-masking particulate jelly beverage
10/14/2009CN100548380C Long-acting sustained-release medicaments for treating and renovating osteomyelitis and preparation thereof
10/14/2009CN100548379C Preparation for skin external use
10/14/2009CN100548378C Method for preparing nanometer sized rapamycin/chitosan enveloped carrier
10/14/2009CN100548306C Injection for treating eperythrozoonosis of domestic animal and its preparation method
10/14/2009CN100548305C Compound vibramycin injection for animals and the preparing method thereof
10/14/2009CN100548302C Female hormone-containing patch
10/14/2009CN100548298C Pantoprazole sodium liposomes freeze-dry preparations and method of preparing the same
10/14/2009CN100548295C Aztreonam liposomes freeze-dry preparations and method of preparing the same
10/14/2009CN100548292C A micro-emulsion containing Vitamin C and Vitamin E
10/14/2009CN100548287C Percutaneous absorption preparation
10/14/2009CN100548286C A solid dispersion of ambroxol hydrochloride and composition thereof
10/14/2009CN100548285C Terbinafine nano milk antifungal medicine and its preparation
10/14/2009CN100548279C Delayed total release gastrointestinal drug delivery system
10/14/2009CN100548278C New preparation method for raising rate of packaging microspheres of naltrexone
10/14/2009CN100548277C Preparing method of powder agglomerates
10/14/2009CN100548274C Water type injection containing paclitaxel and its preparing method
10/14/2009CN100548271C Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
10/13/2009US7601872 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell
10/13/2009US7601817 For treating a disease medicated by TNF alpha including acute and chronic immune and immunoregulatory disorders and rheumatoid or osteo-arthritis
10/13/2009US7601814 Reduce binding to epitope to fusion protein; reduce its ability to interact with a T cell receptor; use in immunotherapy
10/13/2009US7601708 Providing sustained systemic concentrations of therapeutic or prophylactic agents such as gamma-aminobutyric acid derivatives following oral adiminstration to animals
10/13/2009US7601706 Bile-acid conjugates providing for sustained systemic concentration of drugs
10/13/2009US7601705 Polymer controlled induced viscosity fiber system and uses thereof
10/13/2009US7601703 Complexing the target cell with therapeutic agent; antiproliferative agent
10/13/2009US7601688 Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
10/13/2009US7601515 Process of high purity albumin production
10/13/2009US7601511 Biotinylation of compounds such as peptides and peptidomimetics facilitates illicit transport of the compounds into Gram negative bacteria; screening for antibiotics, or in drug delivery of antibiotics
10/13/2009US7601364 Carbohydrate mixtures
10/13/2009US7601363 Water solubility; silicones; vaccines
10/13/2009US7601354 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
10/13/2009US7601347 Methods and compositions for controlled release of bioactive compounds
10/13/2009US7601337 Delivery of antipsychotics through an inhalation route
10/13/2009CA2483916C Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
10/13/2009CA2482405C Multiple compartment bag assembly for dialysis fluid
10/13/2009CA2472373C Combination of paclitaxel and a polymer
10/13/2009CA2445276C Aripiprazole oral solution
10/13/2009CA2438910C Amphoteric sterols and the use thereof in the production of ph-sensitive liposomes
10/13/2009CA2419471C Use of triazinetrione sulphones for controlling coccidioses
10/13/2009CA2414665C Rapidly disintegrating dosage form for releasing active ingredients in the oral cavity or in body cavities
10/13/2009CA2408716C Stable polymeric micelle-type drug composition and method for the preparation thereof
10/13/2009CA2395866C Ophthalmic anti-allergy compositions suitable for use with contact lenses
10/13/2009CA2395438C Dry compositions containing hydrophobic amino acid
10/13/2009CA2373867C Compositions comprising organosiloxane resins for delivering oral care substances
10/13/2009CA2367615C Transdermal therapeutic system with nicotine and addition of monoterpene ketones
10/13/2009CA2356331C Methods for glucagon suppression
10/13/2009CA2351463C Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
10/13/2009CA2326715C Hemoglobin-polysaccharide conjugates
10/13/2009CA2323925C Crosslinkable macromers bearing initiator groups
10/13/2009CA2319515C Anhydrous topical skin preparations
10/13/2009CA2318512C Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
10/13/2009CA2309278C Biodegradable, anionic polymers derived from the amino acid l-tyrosine
10/13/2009CA2236888C Medicament, in particular for modulation of the immune response in the control of viruses, tumors, bacteria and parasites
10/13/2009CA2224413C Immunovectors for the intracellular and intranuclear transport
10/13/2009CA2220339C Toxin conjugates having a spacer comprising polyalkylene glycol and peptide
10/13/2009CA2217485C Controlled release biodegradable nanoparticles containing insulin
10/13/2009CA2215933C Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
10/13/2009CA2180810C Stable gelatin coated acetylsalicylic acid tablets
10/13/2009CA2154488C Ganglioside-klh conjugate vaccines with qs-21
10/13/2009CA2110291C Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
10/10/2009CA2627021A1 Combination natural source/local anesthetic/dual component penetration enhancer topical formulation useful for treating pain, itching and/or inflammation of the skin
10/08/2009WO2009123934A2 Branched multifunctional nanoparticle conjugates and their use
10/08/2009WO2009123304A1 Fine granules having improved suspension performance in water
10/08/2009WO2009123257A1 Soft capsule coating and soft capsule
10/08/2009WO2009123207A1 Oral rinse composition
10/08/2009WO2009123206A1 Oral pharmaceutical composition
10/08/2009WO2009123183A1 Antiviral agent and antiviral composition
10/08/2009WO2009123169A1 Amide derivative-containing pharmaceutical composition
10/08/2009WO2009123103A1 Apparatus for producing liposomes and method of producing liposomes
10/08/2009WO2009123102A1 Processed starch powder with excellent disintegration properties and manufacturing method thereof
10/08/2009WO2009123003A1 Composition for external application to skin
10/08/2009WO2009122719A1 Substance and composition both capable of imparting heat resistance
10/08/2009WO2009122710A1 Medical composition
10/08/2009WO2009122280A1 Pharmaceutical composition and diagnostic and therapeutic use thereof
10/08/2009WO2009121945A2 New formulations, tablets comprising such formulations, their use and process for their preparation
10/08/2009WO2009121884A1 Insulin albumin conjugates
10/08/2009WO2009121804A1 Drug fusions and conjugates
10/08/2009WO2009121759A2 Use of pegylated igf-i variants for the treatment of neuromuscular disorders
10/08/2009WO2009121631A2 Nanoparticles for targeted delivery of active agents to the lung
10/08/2009WO2009121564A1 Drug conjugates with polyglycerols
1 ... 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 ... 1712